Description

Speakers:
Ricardo Rendon ⋅ Urologic Oncologist
Troy Sitland ⋅ Urologist
Krista Noonan ⋅ Medical Oncologist

Virtual Session Sign up >>

Learning Objectives

By the end of this program, participants will be able to:

• Assess and recognize patients with metastatic castration-sensitive prostate cancer (mCSPC), non-metastatic castration-resistant prostate cancer (nmCRPC), and
  metastatic castration-resistant prostate cancer (mCRPC) who require an intensification or change in their treatment strategy
• Integrate recent Canadian guidance for the management of advanced prostate cancer into routine practice
• Facilitate patient referral from community practices to tertiary centres as appropriate for patients with advanced disease to access the appropriate therapies and services